For Healthcare Professionals: Melanoma: Related News

Clinical Updates

On Our Blog

Pictured: Jedd Wolchok
Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

June 4, 2014
Pictured: Jedd Wolchok
Memorial Sloan Kettering’s Jedd Wolchok Describes Stunning Success of Cancer Immunotherapy in New York Times and Scientific American Features

Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American.

May 2, 2014
Pictured: Jedd Wolchok & Richard Carvajal
Memorial Sloan Kettering Researchers Report on Major Advances in the Treatment of Metastatic Eye and Skin Melanoma

Two Memorial Sloan Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

June 3, 2013
Pictured: Jedd Wolchok
Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma

Early research led by investigators at Memorial Sloan Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

April 4, 2013